⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL27943909 | 0.65 | — | — | |
| SCHEMBL6138613 | 0.56 | — | — | |
| SCHEMBL6332789 | 0.56 | — | — | |
| SCHEMBL15223659 | 0.54 | — | — | |
| Formic Acid SCHEMBL27800193 | 0.53 | GSK3A (0.69) | — | |
| SCHEMBL12276842 | 0.53 | GSK3A (0.41) | — | |
| SCHEMBL14602375 | 0.52 | — | — | |
| SCHEMBL1029298 | 0.52 | — | — | |
| SCHEMBL9587810 | 0.49 | GSK3B (0.37) | — | |
| SCHEMBL12481392 | 0.49 | PTPRC (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2177226-B1 | Hydroxamate compositions | COVIDIEN LP (US) | 2013-09-18 | — | — | EP | disclosed |
| US-8425972-B2 | Antimicrobial materials and coatings | COVIDIEN LP (US) | 2013-04-23 | — | — | US | disclosed |
| US-8425972-B2 | Antimicrobial materials and coatings | COVIDIEN LP (US) | 2013-04-23 | — | — | US | disclosed |
| EP-2564859-A1 | Hydroxamate compositions | Covidien LP (US) | 2013-03-06 | — | — | EP | disclosed |
| US-8153741-B2 | Furanone copolymers | TYCO HEALTHCARE GROUP LP (US) | 2012-04-10 | — | — | US | disclosed |
| US-8153741-B2 | Furanone copolymers | TYCO HEALTHCARE GROUP LP (US) | 2012-04-10 | — | — | US | disclosed |
| US-20110280824-A1 | Furanone Copolymers | TYCO HEALTHCARE GROUP LP (US) | 2011-11-17 | — | — | US | disclosed |
| US-20110280824-A1 | Furanone Copolymers | TYCO HEALTHCARE GROUP LP (US) | 2011-11-17 | — | — | US | disclosed |
| US-7999051-B2 | Furanone copolymers | TYCO HEALTHCARE GROUP LP (US) | 2011-08-16 | — | — | US | disclosed |
| US-7999051-B2 | Furanone copolymers | TYCO HEALTHCARE GROUP LP (US) | 2011-08-16 | — | — | US | disclosed |
| US-7923439-B2 | Hydroxamate compositions | TYCO HEALTHCARE GROUP LP (US) | 2011-04-12 | — | — | US | disclosed |
| US-7923439-B2 | Hydroxamate compositions | TYCO HEALTHCARE GROUP LP (US) | 2011-04-12 | — | — | US | disclosed |
| US-20100130713-A1 | FURANONE COPOLYMERS | COVIDIEN LP | 2010-05-27 | — | — | US | disclosed |
| US-20100130713-A1 | FURANONE COPOLYMERS | COVIDIEN LP | 2010-05-27 | — | — | US | disclosed |
| US-20100119695-A1 | ANTIMICROBIAL MATERIALS AND COATINGS | COVIDIEN LP | 2010-05-13 | — | — | US | disclosed |
| US-20100119695-A1 | ANTIMICROBIAL MATERIALS AND COATINGS | COVIDIEN LP | 2010-05-13 | — | — | US | disclosed |
| EP-2177226-A1 | Hydroxamate compositions | Tyco Healthcare Group LP (US) | 2010-04-21 | — | — | EP | disclosed |
| US-20100093846-A1 | HYDROXAMATE COMPOSITIONS | TYCO HEALTHCARE GROUP LP | 2010-04-15 | — | — | US | disclosed |
| US-20100093846-A1 | HYDROXAMATE COMPOSITIONS | TYCO HEALTHCARE GROUP LP | 2010-04-15 | — | — | US | disclosed |
| WO-2008144247-A1 | ANTIMICROBIAL MATERIALS AND COATINGS | TYCO HEALTHCARE GROUP LP (US) | 2008-11-27 | — | — | WO | disclosed |